Navigation Links
Addiction in Biological Technology

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

... the use of CPP-109 for the treatment of cocaine addiction and our proof-of-concept study evaluating the use ... McEnany concluded, "Catalyst, along with leading addiction clinicians across the U.S., continues to seek ... under the NIH umbrella, for future vigabatrin addiction trials and to provide a portion of the required ...

Matt Bars, a Global Expert in Smoking Cessation, Joins Next Safety as Chairman

... and is a member of the American Academy of addiction Psychiatry. He is a consultant and key ... management, and administration of nicotine addiction services since 1980. Mr. Bars is a ... Service). "I have worked against nicotine addiction for almost 30 years and I am excited to be ...

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results

... this trial, having enrolled 186 subjects at 11 addiction centers around the United States. Initial ... CPP-109 for the treatment of methamphetamine addiction using a trial protocol that is almost identical ... of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company ...

Addiction Treatment Finds Success Treating Brain Deficiencies through the Belly

... Arche Wellness, a licensed addiction treatment program near Pittsburgh PA, has found success treating addiction by focusing on patients' malfunctioning ... and amino acids for those struggling with addiction to alcohol, heroin, methadone, buprenorphine and ...

Laser Therapy Gives Smokers Hope for Successful New Year's Resolution

... achieve their goal of breaking their smoking addiction forever," states David Jackson, CEO of Achieve ... Mr. Jackson personally overcame his nicotine addiction after more than 15 years of smoking a pack a day. ... "This allows our clients to overcome their body's addiction faster and without side-effects." For ...

Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that Patrick J. ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced that it has entered ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement

... develops and commercializes prescription drugs for the treatment of drug addiction and obsessive compulsive disorders, today announced the filing of a shelf ... and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from ...

deCODE genetics Announces First Quarter 2008 Financial Results

... genetic factors involved in prostate cancer, breast cancer, nicotine addiction and lung cancer, osteoporosis, intracranial and abdominal aortic ... latter phases of development of DG041. Target Discovery -- Nicotine addiction and lung cancer. In April, deCODE scientists reported a clear link ...

Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions

... hospital and outpatient practice which provides mental health and addiction services to 10,000 persons of all ages annually, will transition clinical ... years ago, Manatee Glens is a not-for-profit provider of mental health and addiction inpatient, detox, residential psychiatric and treatment and counseling ...

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

... antagonist AEZS-123 reduced body weight gain and fat accumulation in an animal model of diet-induced obesity. About the Food and Alcohol addiction Market There is no safe and effective appetite suppressant currently on the market. It is estimated that between 34 million and 61 million ...

Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice

... Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive-compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents in ...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in ...

Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... or next day hangover effects that are commonly associated with other sleep medications. ITI-007 is expected to have a strong safety profile with no addiction liability. This compound is being evaluated for the treatment of sleep disorders in various patient populations with sleep maintenance problems and ...

Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation

... of unanticipated events. About Rock Creek Pharmaceuticals Rock Creek Pharmaceuticals develops pharmaceutical products for treatment of addiction and other neurological disorders. The company supports third-party academic, educational and therapeutic advances in both these areas of research. ...

USC researchers derive first embryonic stem cells from rats

... ES cells will greatly facilitate the creation of rat models for the study of different human diseases, such as cancer, diabetes, high blood pressure, addiction and autoimmune diseases." Ying, a native of China, notes that this breakthrough research occurred during 2008, the Chinese year of the rat. ...

Top 10 Cognitive Fitness Events of 2008 to be Unveiled at SharpBrains' Webinar

... treatments. 8) August: CogniFit secures $5 million from Milk Capital. 9) September: The Paul Wellstone and Pete Domenici Mental Health Parity and addiction Equity Act of 2008 is signed into law. 10) October: Allstate launches a large-scale research project to measure the impact of Posit Science InSight ...

A Better Tomorrow Treatment Center Inc., Forterus Inc.'s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior

... nation to offer GenRecovery, a DNA-customized program for individuals with a genetic predisposition for addictive behavior. "As one of the leading addiction treatment centers in California, A Better Tomorrow is constantly striving to improve its success rate with addiction treatment. And one way to do ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results

... Partners, Inc. is a biopharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction and obsessive compulsive disorders. The Company has obtained from Brookhaven National Laboratory an exclusive worldwide license for nine patents and ...

A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease

... complex health challenges. Not only have we made a convincing link between a single SNP and a behavioral disorder -- greater smoking quantity and addiction to nicotine -- but also demonstrated how this risk factor translates into risk of lung cancer and PAD. This is an important advance that we will use ...

Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting

... and support services designed specifically to help smokers and non-smokers understand and address the two components to smoking cessation: nicotine addiction and habit change. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as ...

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

... extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Alkermes is headquartered in Cambridge, Massachusetts, with research and manufacturing facilities in Massachusetts and Ohio. For more ...

Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics

... medical laboratory specializing in advanced, state-of-the-art clinical quantitative urine drug testing and monitoring for Pain Management, addiction Medicine, Primary Care, Mental Health and Well-Being, Behavioral Health, and Hospital Systems. For more information, please visit ...

PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities

... professional (HCP administered) or self-administered. His expertise includes a broad range of therapeutic areas, including oncology, HIV/AIDS, addiction medicine, hormone replacement therapy, gastroenterology, and urology. Mr. Stevens holds a Bachelor's degree from Northeastern University, an MBA from ...

AIDS and tobacco are worldwide killers: Is bioscience doing enough to stop them?

... Educating the worlds smokers about the dangers of tobacco use is one long-term strategy, Loftus said, but an effective drug to break their addiction would accomplish even more. Its tempting for researchers to focus on the North American and European markets because thats where the money can be ...

UW-Milwaukee Chancellor Santiago determined to build on research base

... six years, and increasing the amount of interdisciplinary research. As examples of high-growth programs, Santiago cited campus research in water, addiction and behaviors, mathematics, medicinal chemistry and Internet-based maintenance solutions for manufacturing. Each program has grown with relatively ...

Are guest worker programs causing backlash amid IT downsizing?

... American worker replacement program in disguise. All American workers in all job categories and pay scales can be replaced by this program. The addiction U.S. employers have for exploiting non-immigrant guest worker visa programs and sending jobs overseas has caused significant losses in wealth and ...

Bush praises Johnson Controls battery tech in Milwaukee visit

... but rather than concentrate on traditional energy resources, his remarks were directed toward new methods of treating what he called the nation's addiction to foreign oil. In an address before employees at Johnson Controls, a Milwaukee-based automotive battery manufacturer that is developing a new ...

Doyle, Kind call for higher renewable fuel standard

... be comprised of renewable fuels like ethanol by 2015. "Increasing the federal renewable fuel standard would be a major step toward kicking our addiction to foreign oil," Doyle said. "We have the resources and the ingenuity to get this done." The standard, which some credit with accelerating growth ...

Wisconsin will have plenty of competition in building the energy future

... With new technology, and a commitment to renewable fuels, Wisconsin can lead the way - reducing global warming and helping this nation kick its addiction to foreign oil. The Office on Energy Independence will coordinate the state's efforts to grow Wisconsin's bio and renewable economies and advise ...
Other Contents
(Date:7/10/2014)... 27, 2014  The American Academy of Forensic ... Standards and Technology (NIST) and the Department of ... and forensic science expert members to the Forensic ... element of the NIST,s Organization of Scientific Area ... first appointments made to the new FSSB that ...
(Date:7/10/2014)... 2014  Aware, Inc. (NASDAQ: AWRE ), ... announced on June 26, 2014 that its Board of ... per share, or approximately $40 million in total.  The ... and a payment date of July 24, 2014.  The ... set an ex-dividend date for this special cash dividend. ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... , Unisys Nederland N.V., today announced that it has been ... implement and manage a new Basic Provision Biometrics solution for ... Unisys won the contract with a solution based on ... software. The term of the contract is up to seven ...
Breaking Biology News(10 mins):Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 2Ten Members of the American Academy of Forensic Sciences Appointed to Forensic Science Standards Board (FSSB) 3NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
(Date:7/12/2014)... 12, 2014 Tylenol lawsuits ( ... move forward in the federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. According to a filing ... F. Stengel has ordered the deposition of a ... found that the witness’s testimony concerning the marketing ...
(Date:7/12/2014)... -- Burn injuries increase in the summer as people gather ... Among those most vulnerable to these seasonal fire hazards: children. ... get burned by putting their hands on the side of ... unit at Loyola University Medical Center in Maywood, Ill., said ... ,When you play with fire, you get burned, is true ...
(Date:7/12/2014)... 12, 2014 “After my mom’s stroke, she loss ... stroke and loss the use of his left side. Eating became ... way to help people like them enjoy eating again,” said an ... for the PATRICIA CAROL HALL PLATE (P C H PLATE). , ... more ergonomic way to eat for individuals who suffer from stroke, ...
(Date:7/12/2014)... prom shopping reaching its final days, VogueQueen.com, a renowned ... its new and trendy apparels. Recently, the company has ... online shop. Additionally, it is now providing huge discounts ... to the company’s sales manager, the promotion will come ... He says, “Now, worldwide clients can order cheap ...
(Date:7/12/2014)... “Critical Care Therapeutics in Major Developed ... PCCs and Recombinant Products to Drive Market,” which ... in the US, UK, France, Germany, Italy, Spain, ... of market size for 2013, along with market ... that are being treated using the five major ...
Breaking Medicine News(10 mins):Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 2Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 3Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 4Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 5Health News:Critical Care Therapeutics in Major Developed Market is Expected to Grow at a CAGR of 4.7% to $2.5 Billion in 2019 6
Other TagsOther Tags